Nociception: Taking the Pain out of Drug Discovery. 28 November 2006, London, UK.
Norman
Peter
P
Norman Consulting, 18 Pink Lane, Burnham, Buckinghamshire, SL1 8JW, UK. petrosn@bigfoot.com
D000581:Amidohydrolases / Q000037:antagonists & inhibitors; D000588:Amines / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D000077206:Gabapentin; D062558:NAV1.9 Voltage-Gated Sodium Channel; D009479:Neuropeptides / Q000037:antagonists & inhibitors; D009619:Nociceptors / Q000187:drug effects*; D010146:Pain / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D010523:Peripheral Nervous System Diseases / Q000150:complications; D043885:Receptor, Cannabinoid, CB2 / Q000819:agonists; D018094:Receptors, Metabotropic Glutamate / Q000037:antagonists & inhibitors; D015222:Sodium Channels; D050916:TRPV Cation Channels / Q000037:antagonists & inhibitors; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use; D000099252:Fatty Acid Amide Hydrolases
D000581:Amidohydrolases; D000588:Amines; D000700:Analgesics; D003509:Cyclohexanecarboxylic Acids; D000077206:Gabapentin; D062558:NAV1.9 Voltage-Gated Sodium Channel; D009479:Neuropeptides; D043885:Receptor, Cannabinoid, CB2; D018094:Receptors, Metabotropic Glutamate; D015222:Sodium Channels; D050916:TRPV Cation Channels; D005680:gamma-Aminobutyric Acid; D000099252:Fatty Acid Amide Hydrolases; C491886:SCN11A protein, human; C494482:TRPV1 protein, human; C104077:metabotropic glutamate receptor type 1